Principles of Immunosuppression in the Management of Kidney Disease: Core Curriculum 2022.

Kant, Sam; Kronbichler, Andreas; Geetha, Duvuru

Kant, Sam; Kronbichler, Andreas; Geetha, Duvuru.

Affiliation

Kant S; Division of Nephrology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Kronbichler A; Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Geetha D; Division of Nephrology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland. Electronic address: gduvura@jhmi.edu.

Am J Kidney Dis ; 80(3): 393-405, 2022 09.

Article in En | MEDLINE | ID: mdl-35440396

Subject(s)

Kidney Diseases; Mycophenolic Acid; Aged; Curriculum; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents/adverse effects; Kidney Diseases/chemically induced; Mycophenolic Acid/therapeutic use; Pregnancy

Key words

Acute kidney injury (AKI); adverse effects; azathioprine; calcineurin inhibitors (CNIs); corticosteroids; cyclophosphamide; glomerular disease; immunomodulation; immunosuppression; intravenous immune globulin (IVIG); mycophenolate mofetil (MMF); review; rituximab

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Diseases / Mycophenolic Acid Limits: Aged / Female / Humans / Pregnancy Language: En Journal: Am J Kidney Dis Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google